Jeremy Cubert joined Dickstein Shapiro in 1999 and is a partner in the Intellectual Property Practice. He focuses his practice on biotechnology and chemical intellectual property law including patent prosecution, licensing and technology transfer, litigation, due diligence, and client counseling pertaining to the use and acquisition of intellectual property. Mr. Cubert has been employed in the area of intellectual property law since 1992. He served as a scientist and technology transfer specialist for the National Cancer Institute and later as a staff attorney for the Federal Trade Commission. Mr. Cubert advises clients regarding intellectual property acquisition and enforcement for technologies ranging from genomics and recombinant organisms to pharmaceuticals and medical devices.
